1. Home
  2. RVSB vs PEPG Comparison

RVSB vs PEPG Comparison

Compare RVSB & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

HOLD

Current Price

$5.75

Market Cap

117.7M

Sector

Finance

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$1.80

Market Cap

121.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVSB
PEPG
Founded
1923
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.7M
121.7M
IPO Year
1997
2022

Fundamental Metrics

Financial Performance
Metric
RVSB
PEPG
Price
$5.75
$1.80
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$7.00
$11.17
AVG Volume (30 Days)
46.3K
650.1K
Earning Date
04-28-2026
05-14-2026
Dividend Yield
1.55%
N/A
EPS Growth
N/A
25.61
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$53.63
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.74
$1.01
52 Week High
$6.22
$7.80

Technical Indicators

Market Signals
Indicator
RVSB
PEPG
Relative Strength Index (RSI) 48.85 60.50
Support Level $5.33 $1.55
Resistance Level $5.79 $5.37
Average True Range (ATR) 0.24 0.10
MACD -0.02 0.07
Stochastic Oscillator 16.90 75.48

Price Performance

Historical Comparison
RVSB
PEPG

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is the bank holding company. The Company's operations are managed along two operating segments, consisting of banking operations performed by the Bank and trust and investment services performed by the Trust Company. The Bank is engaged mainly in the business of attracting deposits from the general public and using such funds, together with other borrowings, to make various commercial business, commercial real estate, land, multi-family real estate, real estate construction and consumer loans. Additionally, the Trust Company offers trust and investment services. It has single operating segment.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: